StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)

Close on Nov 17, 2026Market cap $3.00BP/E –Yield –

Telix Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Telix Pharmaceuticals's pe ratio was 74.3× on Feb 27, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 202674.3×−2.5
2025Dec 31, 202576.7×–

More Telix Pharmaceuticals figures

See a number that looks wrong?